2023
DOI: 10.1016/j.surg.2023.02.020
|View full text |Cite
|
Sign up to set email alerts
|

The PD-ROBOSCORE: A difficulty score for robotic pancreatoduodenectomy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 56 publications
0
3
0
Order By: Relevance
“…In this score, 2 of the 5 difficulty parameters have clear implications for PD-VR (ie, borderline resectable pancreatic tumor and tumor located in the uncinate process of the pancreas). 40 Therefore, it is important to note that robotic PD-VR did not increase the incidence of SPC compared to open PD-VR.…”
Section: Discussionmentioning
confidence: 94%
“…In this score, 2 of the 5 difficulty parameters have clear implications for PD-VR (ie, borderline resectable pancreatic tumor and tumor located in the uncinate process of the pancreas). 40 Therefore, it is important to note that robotic PD-VR did not increase the incidence of SPC compared to open PD-VR.…”
Section: Discussionmentioning
confidence: 94%
“…This may be operationalized by devising strict national and international surgical society guidelines. Further, utilization of risk prediction scores like Difficulty scoring system (DSS)[ 49 ] or PD-ROBOSCORE [ 50 ] will likely aid better patient selection for MIPD.…”
Section: Discussionmentioning
confidence: 99%
“… 1 Several retrospective studies have demonstrated that robotic pancreatoduodenectomy (RPD) may be comparable to open PD (OPD), although the criteria for patient selection remain contentious. 2 , 3 Furthermore, while approximately 40 RPD cases are needed to overcome the initial learning curve, the full potential of RPD may not be realized until 250 procedures. 4 The importance of achieving proficiency in minimally invasive pancreatoduodenectomy before implementing randomised controlled trials (RCTs) was highlighted by the LEOPARD-2 trial, which was closed due to safety concerns.…”
mentioning
confidence: 99%